• Spectral AI filed an NTAP application with CMS for its DeepView System, seeking add-on Medicare inpatient reimbursement via the alternative pathway.
• CMS is expected to issue a final decision in August 2027; NTAP status would start in October 2027 if granted.
• DeepView received FDA De Novo classification in May 2026 for AI-based, non-invasive burn-wound healing assessment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spectral Ai Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610060830PRIMZONEFULLFEED9840005) on October 06, 2026, and is solely responsible for the information contained therein.